A quick revision guide covering key concepts, biomolecules, cell organelles, and essential NEET-style MCQs to boost exam ...
BEIJING, Dec. 09, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today ...
XmAb819 demonstrated a manageable safety profile with primarily grade 1 or 2 cytokine release syndrome and no neurotoxicity in ccRCC patients. The trial involved 69 patients, with a 25% objective ...
Exicure, a clinical-stage biotechnology company specializing in next-generation stem-cell mobilization therapies, has staged a massive rally.
Patients with immune thrombocytopenia (ITP) who received a first-in-class investigational drug in addition to standard ...
RMAT designation indicates that SENTI-202 has the potential to address unmet medical needs for patients with Relapsed/Refractory (R/R) Acute ...
New data show 100% (6/6) objective response rate (ORR) with EO2463 in previously untreated patients with follicular lymphoma needing treatment in combination with rituximab (SIDNEY Cohort 3) -- Of the ...
Inaugural Members of the Akadeum CDMO Alliance: ElevateBio (R) and Charles River. Akadeum has collaborated with both CDMOs, establishing strong data sets demonstrating reduced impurities and high ...
Where the BYDs are for everyone, a Yangwang is a cut above—luxury, performance, and a lil bit of "better than you." It's ...
The ninth edition of Prime Minister Narendra Modi's annual Pariksha Pe Charcha will be held in January 2026, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback